Perspective Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2003
Revenue	1.43	0	10.05	9.68	7.31	5.92	4.76	4.77	4.61	4.22	Upgrade
Revenue Growth (YoY)	-	-	3.85%	32.35%	23.48%	24.41%	-0.17%	3.54%	9.17%	-6.76%	Upgrade
Cost of Revenue	0	0	4.93	4.56	4.27	4.08	3.92	4.64	4.44	4.42	Upgrade
Gross Profit	1.43	0	5.12	5.12	3.05	1.84	0.84	0.13	0.17	-0.2	Upgrade
Selling, General & Admin	21.06	5.57	7.13	7.55	6.85	6.83	6.23	5.14	3.89	3.72	Upgrade
Research & Development	21.31	0.85	1.43	1.13	1.47	1.75	0.97	0.53	0.62	0.67	Upgrade
Other Operating Expenses	0	0	0.01	-0.07	-0.02	0	-0.05	-0.46	0	0	Upgrade
Operating Expenses	42.38	6.42	8.57	8.6	8.3	8.57	7.15	5.21	4.5	4.39	Upgrade
Operating Income	-40.94	-6.42	-3.45	-3.48	-5.25	-6.73	-6.31	-5.08	-4.34	-4.59	Upgrade
Interest Expense / Income	0.08	0	0	0	0	0	0	0	0	0	Upgrade
Other Expense / Income	8.13	0.85	-0.06	-0.03	-0.11	-0.03	-0.15	-0.37	-0.66	1.37	Upgrade
Pretax Income	-49.16	-7.27	-3.39	-3.45	-5.14	-6.7	-6.16	-4.71	-3.68	-5.96	Upgrade
Income Tax	-2.65	0	0	0	0	0	0	0	0	0	Upgrade
Net Income	-46.51	-7.27	-3.39	-3.45	-5.14	-6.7	-6.16	-4.71	-3.68	-5.96	Upgrade
Preferred Dividends	0	0	0	0.01	0.01	0.01	0.01	0.01	0.01	0.74	Upgrade
Net Income Common	-46.51	-7.27	-3.39	-3.46	-5.16	-6.71	-6.17	-4.72	-3.69	-6.7	Upgrade
Shares Outstanding (Basic)	268	142	104	68	67	55	55	55	55	43	Upgrade
Shares Outstanding (Diluted)	268	142	104	68	67	55	55	55	55	43	Upgrade
Shares Change	88.50%	36.74%	53.61%	0.83%	21.54%	0.26%	0.00%	0.24%	28.60%	23.97%	Upgrade
EPS (Basic)	-0.17	-0.05	-0.03	-0.05	-0.08	-0.12	-0.11	-0.09	-0.07	-0.16	Upgrade
EPS (Diluted)	-0.17	-0.05	-0.03	-0.05	-0.08	-0.12	-0.11	-0.09	-0.07	-0.16	Upgrade
Free Cash Flow	-37.99	-7.98	-3.22	-3.91	-5.46	-6.05	-6.26	-4.36	-3.66	-3.25	Upgrade
Free Cash Flow Per Share	-0.14	-0.06	-0.03	-0.06	-0.08	-0.11	-0.11	-0.08	-0.07	-0.08	Upgrade
Gross Margin	100.00%	-	50.94%	52.93%	41.66%	31.10%	17.60%	2.70%	3.63%	-4.66%	Upgrade
Operating Margin	-2855.02%	-	-34.28%	-35.91%	-71.83%	-113.61%	-132.47%	-106.56%	-94.16%	-108.75%	Upgrade
Profit Margin	-3243.24%	-	-33.72%	-35.71%	-70.48%	-113.30%	-129.66%	-99.01%	-80.16%	-158.71%	Upgrade
Free Cash Flow Margin	-2648.88%	-	-32.00%	-40.43%	-74.64%	-102.13%	-131.38%	-91.49%	-79.35%	-76.96%	Upgrade
EBITDA	-48.01	-6.98	-3.2	-3.26	-4.96	-6.57	-6.05	-4.13	-3.07	-5.24	Upgrade
EBITDA Margin	-3348.26%	-	-31.80%	-33.65%	-67.79%	-110.92%	-127.05%	-86.64%	-66.57%	-124.26%	Upgrade
Depreciation & Amortization	1.06	0.29	0.19	0.19	0.19	0.13	0.11	0.58	0.61	0.72	Upgrade
EBIT	-49.08	-7.27	-3.39	-3.45	-5.14	-6.7	-6.16	-4.71	-3.68	-5.96	Upgrade
EBIT Margin	-3422.25%	-	-33.69%	-35.60%	-70.33%	-113.12%	-129.43%	-98.76%	-79.87%	-141.22%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).